发明名称 USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION
摘要 D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen- free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
申请公布号 CA2757442(A1) 申请公布日期 2009.10.08
申请号 CA20092757442 申请日期 2009.04.02
申请人 BIOENERGY, INC. 发明人 ST. CYR, JOHN A.;PERKOWSKI, DAVID J.
分类号 A61K31/7004;A61K31/616;A61K33/00;A61K45/06;A61P9/10 主分类号 A61K31/7004
代理机构 代理人
主权项
地址
您可能感兴趣的专利